Upstate helps lead global trial that could change heart failure care
Overview
Upstate Medical University has enrolled the first patient in a landmark international clinical trial that could reshape treatment for heart failure patients with cardiomyopathy and electrical conduction issues, with Upstate cardiologist Jorge E. Romero serving as one of two principal investigators leading the study worldwide.
Upstate will enroll three more patients later this month.
The international study will enroll between 850 and 1,110 participants at sites across the United States, Europe, Asia and Australia.
The Big Picture
Up to 315 million people worldwide suffer from ischemic heart disease. Heart disease is the No. 1 cause of death in the United States.
Upstate is one of only 29 study locations in the United States, and one of four in New York. Other New York locations are Rochester General Hospital, New York Hospital in Queens and Weill Cornell Medical University in Manhattan. The Division of Cardiology oversees Upstate’s participation in collaboration with Upstate’s Global Health Institute.
